ViGeneron GmbH
October 25, 2023
ViGeneron GmbH
Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology
View Article
August 22, 2023
ViGeneron GmbH
ViGeneron announces EMA Approval of Clinical Trial Application for VG901, a gene therapy to treat Retinitis Pigmentosa
View Article
October 11, 2022
ViGeneron GmbH
ViGeneron presents preclinical data on intravitreal gene therapy of Stargardt disease at ESGCT
View Article